Abstract
Structure-based design, chemical synthesis and biochemical testing of a series of novel Smac peptido-mimetics as inhibitors of XIAP protein are described. The most potent compound, 6j, has a binding affinity (K(i) value) of 24 nM to XIAP BIR3 protein and is 24 times more potent than the native Smac AVPI peptide. Further optimization of these potent Smac mimetics may ultimately lead to the development of a novel class of anticancer drugs for the treatment of human cancer by overcoming apoptosis-resistance of cancer cells through targeting the inhibitor of apoptosis proteins.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Apoptosis Regulatory Proteins
-
Binding Sites
-
Carrier Proteins / chemistry*
-
Drug Design*
-
Humans
-
Hydrophobic and Hydrophilic Interactions
-
Intracellular Signaling Peptides and Proteins
-
Magnetic Resonance Spectroscopy
-
Mitochondrial Proteins / chemistry*
-
Models, Molecular
-
Molecular Mimicry
-
Peptides / chemical synthesis*
-
Peptides / pharmacology*
-
Protein Binding
-
Proteins / antagonists & inhibitors*
-
Structure-Activity Relationship
-
X-Linked Inhibitor of Apoptosis Protein
Substances
-
Apoptosis Regulatory Proteins
-
Carrier Proteins
-
DIABLO protein, human
-
Intracellular Signaling Peptides and Proteins
-
Mitochondrial Proteins
-
Peptides
-
Proteins
-
X-Linked Inhibitor of Apoptosis Protein
-
XIAP protein, human